• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在模拟宿主环境的多应激系统中对异烟肼治疗的适应性反应

Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment.

作者信息

Yimcharoen Manita, Saikaew Sukanya, Wattananandkul Usanee, Phunpae Ponrut, Intorasoot Sorasak, Tayapiwatana Chatchai, Butr-Indr Bordin

机构信息

Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Antibiotics (Basel). 2023 May 5;12(5):852. doi: 10.3390/antibiotics12050852.

DOI:10.3390/antibiotics12050852
PMID:37237755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10215434/
Abstract

Isoniazid (INH) is an antibiotic that is widely used to treat tuberculosis (TB). Adaptation to environmental stress is a survival strategy for and is associated with antibiotic resistance development. Here, mycobacterial adaptation following INH treatment was studied using a multi-stress system (MS), which mimics host-derived stress. Mtb H37Rv (drug-susceptible), mono-isoniazid resistant (INH-R), mono-rifampicin resistant (RIF-R), and multidrug-resistant (MDR) strains were cultivated in the MS with or without INH. The expression of stress-response genes (, , , and ) and lipoarabinomannan (LAM)-related genes (, , , , , and ), which play important roles in the host-pathogen interaction, were measured using real-time PCR. The different adaptations of the drug-resistant (DR) and drug-susceptible (DS) strains were presented in this work. and were up-regulated in the DR strains in the MS, implying their roles as markers of virulence and potential drug targets. In the presence of INH, , , and were up-regulated in the INH-R and RIF-R strains, while and LAM-related genes were up-regulated in the H37Rv strain. This study demonstrates the complexity of mycobacterial adaptation through stress response regulation and LAM expression in response to INH under the MS, which could potentially be applied for TB treatment and monitoring in the future.

摘要

异烟肼(INH)是一种广泛用于治疗结核病(TB)的抗生素。适应环境压力是一种生存策略,与抗生素耐药性的产生有关。在此,使用模拟宿主来源压力的多应激系统(MS)研究了异烟肼治疗后分枝杆菌的适应性。将结核分枝杆菌H37Rv(药物敏感株)、单异烟肼耐药(INH-R)株、单利福平耐药(RIF-R)株和耐多药(MDR)株在有或无异烟肼的MS中培养。使用实时PCR检测在宿主-病原体相互作用中起重要作用的应激反应基因(、、、和)和脂阿拉伯甘露聚糖(LAM)相关基因(、、、、和)的表达。这项工作展示了耐药(DR)株和药物敏感(DS)株的不同适应性。在MS中,和在DR株中上调,这意味着它们作为毒力标志物和潜在药物靶点的作用。在异烟肼存在的情况下,、和在INH-R和RIF-R株中上调,而和LAM相关基因在H37Rv株中上调。本研究证明了在MS下分枝杆菌通过应激反应调节和LAM表达对异烟肼产生适应性的复杂性,这在未来可能应用于结核病的治疗和监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/3a15f6484ded/antibiotics-12-00852-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/466c8b2e28c1/antibiotics-12-00852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/63d87e0c3b37/antibiotics-12-00852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/c14a0aee45c4/antibiotics-12-00852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/17275246fb01/antibiotics-12-00852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/de3273cde4ec/antibiotics-12-00852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/9015becd292d/antibiotics-12-00852-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/3a15f6484ded/antibiotics-12-00852-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/466c8b2e28c1/antibiotics-12-00852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/63d87e0c3b37/antibiotics-12-00852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/c14a0aee45c4/antibiotics-12-00852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/17275246fb01/antibiotics-12-00852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/de3273cde4ec/antibiotics-12-00852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/9015becd292d/antibiotics-12-00852-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138c/10215434/3a15f6484ded/antibiotics-12-00852-g007.jpg

相似文献

1
Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment.在模拟宿主环境的多应激系统中对异烟肼治疗的适应性反应
Antibiotics (Basel). 2023 May 5;12(5):852. doi: 10.3390/antibiotics12050852.
2
The Regulation of ManLAM-Related Gene Expression in with Different Drug Resistance Profiles Following Isoniazid Treatment.异烟肼治疗后不同耐药谱的人脂阿拉伯甘露聚糖相关基因表达调控
Infect Drug Resist. 2022 Feb 5;15:399-412. doi: 10.2147/IDR.S346869. eCollection 2022.
3
Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.评价 Anyplex™ II MTB/MDR 试剂盒在快速检测来自各种临床标本的异烟肼和利福平耐药结核分枝杆菌方面的性能。
Mol Biol Rep. 2020 Apr;47(4):2501-2508. doi: 10.1007/s11033-020-05331-8. Epub 2020 Mar 2.
4
Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.使用雅培实时结核分枝杆菌检测和利福平/异烟肼耐药性检测方法直接检测呼吸道标本中的结核分枝杆菌及耐药性。
Diagn Microbiol Infect Dis. 2017 Oct;89(2):118-124. doi: 10.1016/j.diagmicrobio.2017.06.018. Epub 2017 Jul 1.
5
Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.雅培实时MTB利福平/异烟肼耐药性检测法的分析及临床性能特征,该检测法用于检测肺部标本中耐利福平和异烟肼的结核分枝杆菌。
Tuberculosis (Edinb). 2016 Dec;101:137-143. doi: 10.1016/j.tube.2016.09.006. Epub 2016 Sep 22.
6
Estimating tuberculosis drug resistance amplification rates in high-burden settings.估算高负担地区的结核耐药扩增率。
BMC Infect Dis. 2022 Jan 24;22(1):82. doi: 10.1186/s12879-022-07067-1.
7
Validation of the GenoType MTBDR Ver 2.0 assay for detection of rifampicin and isoniazid resistance in complex isolates at UZCHS-CTRC TB research laboratory.在UZCHS-CTRC结核病研究实验室对GenoType MTBDR Ver 2.0检测法检测复杂分离株中利福平及异烟肼耐药性的验证。
Int J Mycobacteriol. 2019 Jan-Mar;8(1):83-88. doi: 10.4103/ijmy.ijmy_170_18.
8
Clinical evaluation of the cobas® MTB-RIF/INH reagent and the cobas® 6800 for the detection of isoniazid and rifampicin resistance.cobas® MTB-RIF/INH 试剂和 cobas® 6800 检测异烟肼和利福平耐药性的临床评估。
Tuberculosis (Edinb). 2022 May;134:102199. doi: 10.1016/j.tube.2022.102199. Epub 2022 Mar 21.
9
Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.在埃塞俄比亚西南部,使用Xpert MTB/RIF快速检测肺结核患者中耐利福平的结核分枝杆菌。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S48-S49. doi: 10.1016/j.ijmyco.2016.09.002. Epub 2016 Nov 5.
10
Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.巴西结核分枝杆菌临床分离株的耐药性:表型和基因型方法。
Biomed Pharmacother. 2011 Sep;65(6):456-9. doi: 10.1016/j.biopha.2011.04.021. Epub 2011 Jun 12.

引用本文的文献

1
Prominent transcriptomic changes in Mycobacterium intracellulare under acidic and oxidative stress.分枝杆菌属细胞内菌在酸性和氧化应激下的显著转录组变化。
BMC Genomics. 2024 Apr 17;25(1):376. doi: 10.1186/s12864-024-10292-4.

本文引用的文献

1
Phenotypic adaptation of to host-associated stressors that induce persister formation.对导致持续生存菌形成的宿主相关应激源的表型适应。
Front Cell Infect Microbiol. 2022 Sep 27;12:956607. doi: 10.3389/fcimb.2022.956607. eCollection 2022.
2
Fatty acid metabolism of : A double-edged sword.脂肪酸代谢:一把双刃剑。
Microb Cell. 2022 Feb 28;9(5):123-125. doi: 10.15698/mic2022.05.777. eCollection 2022 May 2.
3
The Regulation of ManLAM-Related Gene Expression in with Different Drug Resistance Profiles Following Isoniazid Treatment.
异烟肼治疗后不同耐药谱的人脂阿拉伯甘露聚糖相关基因表达调控
Infect Drug Resist. 2022 Feb 5;15:399-412. doi: 10.2147/IDR.S346869. eCollection 2022.
4
Insights into the molecular determinants involved in persistence and their therapeutic implications.深入了解参与持续存在的分子决定因素及其治疗意义。
Virulence. 2021 Dec;12(1):2721-2749. doi: 10.1080/21505594.2021.1990660.
5
HspX-mediated survival pathways of pathogenic mycobacteria.热休克蛋白 X(HspX)介导的致病性分枝杆菌生存途径。
Saudi Med J. 2021 Jul;42(7):721-727. doi: 10.15537/smj.2021.42.7.20200582.
6
Evolution of Drug-Resistant Strains and Their Adaptation to the Human Lung Environment.耐药菌株的进化及其对人类肺部环境的适应
Front Microbiol. 2021 Feb 4;12:612675. doi: 10.3389/fmicb.2021.612675. eCollection 2021.
7
Role of post-translational modifications in the acquisition of drug resistance in Mycobacterium tuberculosis.翻译:翻译后修饰在结核分枝杆菌获得耐药性中的作用。
FEBS J. 2021 Jun;288(11):3375-3393. doi: 10.1111/febs.15582. Epub 2020 Oct 23.
8
Orphan response regulator Rv3143 increases antibiotic sensitivity by regulating cell wall permeability in Mycobacterium smegmatis.孤儿应答调节蛋白 Rv3143 通过调节分枝杆菌细胞壁通透性增加抗生素敏感性。
Arch Biochem Biophys. 2020 Oct 15;692:108522. doi: 10.1016/j.abb.2020.108522. Epub 2020 Aug 8.
9
The mycobacterial cell envelope - a moving target.分枝杆菌的细胞包膜——一个移动的目标。
Nat Rev Microbiol. 2020 Jan;18(1):47-59. doi: 10.1038/s41579-019-0273-7. Epub 2019 Nov 14.
10
Lipoarabinomannan in Active and Passive Protection Against Tuberculosis.脂阿拉伯甘露聚糖在结核病主动和被动保护中的作用。
Front Immunol. 2019 Sep 11;10:1968. doi: 10.3389/fimmu.2019.01968. eCollection 2019.